A Comparison of Telemedical and Conventional Antihypertensive Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00282334|
Recruitment Status : Completed
First Posted : January 26, 2006
Results First Posted : July 29, 2011
Last Update Posted : August 1, 2011
The aim of the study is to compare telemedical antihypertensive treatment based on home blood pressure monitoring and conventional antihypertensive treatment based on monitoring of blood pressure in the doctor's office.
We want to test the hypotheses that telemedical treatment is more effective in lowering blood pressure, provide better quality of life and is more cost-effective.
|Condition or disease||Intervention/treatment||Phase|
|Hypertension||Device: Telemedical blood pressure monitoring||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||236 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Comparison of Telemedical and Conventional Antihypertensive Treatment|
|Study Start Date :||May 2004|
|Primary Completion Date :||December 2008|
|Study Completion Date :||December 2008|
|Experimental: Home blood pressure telemonitoring||
Device: Telemedical blood pressure monitoring
Measurement of home blood pressure, three times per week for three months and once a week for three months.
|No Intervention: Conventional blood pressure monitoring|
- Difference in Number of Patients Who Reached Target Blood Pressure [ Time Frame: 6 months ]
- Difference in Mean Daytime Systolic Ambulatory Blood Pressure From Baseline to Follow-up After Six Months [ Time Frame: baseline and 6 months ]Comparison of mean change in daytime systolic ambulatory blood pressure from baseline to follow up after 6 months between the two groups
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00282334
|Dept. of Medical Research, Holstebro Hospital|
|Holstebro, Denmark, 7500|
|Principal Investigator:||Line B Madsen, MD||Dept. of Medical Research, Holstebro Hospital, 7500 Holstebro, Denmark|
|Study Chair:||Erling B Pedersen, Professor||Dept. of Medical Research, Holstebro Hospital, 7500 Holstebro, Denmark|